Biogen gains as cost-cutting drives earnings

Biogen Inc. (NASDAQ:BIIB) added $13.71 to $279.60 on Thursday after it reported 1Q16 earnings that narrowly missed consensus revenue estimates, but topped non-GAAP EPS expectations

Read the full 250 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE